C D Mullins

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi request reprint New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study
    Jingshu Wang
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Ann Pharmacother 41:937-43. 2007
  2. ncbi request reprint Economic analysis of triptan therapy for acute migraine: a Medicaid perspective
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Pharmacotherapy 27:1092-101. 2007
  3. doi request reprint Societal implications of the pharmacoeconomics of alpha1-antitrypsin deficiency
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 100 N Greene Street, Room 612, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 2:243-9. 2002
  4. doi request reprint Impact of the fourth hurdle on the international pharmaceutical industry
    C Daniel Mullins
    Dept of Pharmacy Practice and Science, 515 W Lombard St, 2nd Floor, Baltimore, Maryland, MD 21201 1563, USA
    Expert Rev Pharmacoecon Outcomes Res 3:169-77. 2003
  5. doi request reprint Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectives
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland Electronic address
    Clin Ther 38:2676-2681. 2016
  6. pmc Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    BMC Med Res Methodol 14:1. 2014
  7. pmc From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer
    Richard J Willke
    Pfizer, Inc, 235 E, 42nd Street, New York, NY 10017, USA
    BMC Med Res Methodol 12:185. 2012
  8. pmc Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Transplantation 95:463-9. 2013
  9. ncbi request reprint A qualitative evaluation of a citywide Community Health Partnership program
    C Daniel Mullins
    University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Saratoga Building, 12th Floor, 220 Arch St, Baltimore, MD 21201, USA
    J Natl Med Assoc 104:53-60. 2012
  10. doi request reprint Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Cancer 118:3173-81. 2012

Collaborators

Detail Information

Publications116 found, 100 shown here

  1. ncbi request reprint New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study
    Jingshu Wang
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Ann Pharmacother 41:937-43. 2007
    ..However, less is known about how the risk of hypertension is associated with cyclooxygenase 2 selective inhibitors (coxibs), especially celecoxib, the only coxib remaining on the market...
  2. ncbi request reprint Economic analysis of triptan therapy for acute migraine: a Medicaid perspective
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Pharmacotherapy 27:1092-101. 2007
    ..To compare triptan therapies for migraine in terms of the cost to treat 100 migraine attacks and the cost per successfully treated patient (cost/success), by analyzing utilization and reimbursement data from state Medicaid programs...
  3. doi request reprint Societal implications of the pharmacoeconomics of alpha1-antitrypsin deficiency
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 100 N Greene Street, Room 612, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 2:243-9. 2002
    ..In this review, we provide an overview of published research findings concerning the effectiveness of current therapy, reimbursement and cost issues and potential future advances in treatment for alpha(1)-antitrypsin deficiency...
  4. doi request reprint Impact of the fourth hurdle on the international pharmaceutical industry
    C Daniel Mullins
    Dept of Pharmacy Practice and Science, 515 W Lombard St, 2nd Floor, Baltimore, Maryland, MD 21201 1563, USA
    Expert Rev Pharmacoecon Outcomes Res 3:169-77. 2003
    ..The paper concludes with a hypothetical example for calculating the monetary impact of the fourth hurdle on society when making formulary decisions related to three drugs within a therapeutic class...
  5. doi request reprint Value of Propensity Score Matching for Equalizing Comparator Groups in Observational Database Studies: A Case Study in Anti-infectives
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland Electronic address
    Clin Ther 38:2676-2681. 2016
    ..An observational case study was developed to demonstrate the impact of propensity score adjustments on outcomes (ie, discharge status) of patients hospitalized for complicated intra-abdominal infections...
  6. pmc Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    BMC Med Res Methodol 14:1. 2014
    ..The prevalence and consequences of bone metastases (BM) have been examined across tumor sites using healthcare claims data however the reliability of these claims-based BM measures has not been investigated...
  7. pmc From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer
    Richard J Willke
    Pfizer, Inc, 235 E, 42nd Street, New York, NY 10017, USA
    BMC Med Res Methodol 12:185. 2012
    ..By guiding the selection of the methods and analysis, this review is meant to better enable outcomes researchers to understand and explore aspects of HTE in the context of patient-centered outcomes research...
  8. pmc Benefits Improvement and Protection Act's impact on transplantation rates among elderly MEDICARE beneficiaries with end-stage renal disease
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Transplantation 95:463-9. 2013
    ..Our objective was to determine BIPA's impact on renal transplantation among elderly patients (age ≥65 years) affected by BIPA...
  9. ncbi request reprint A qualitative evaluation of a citywide Community Health Partnership program
    C Daniel Mullins
    University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Saratoga Building, 12th Floor, 220 Arch St, Baltimore, MD 21201, USA
    J Natl Med Assoc 104:53-60. 2012
    ..Through stakeholder engagement, many more communities beyond Baltimore can become better networked to help patients navigate the health care system and improve their health...
  10. doi request reprint Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Cancer 118:3173-81. 2012
    ..Whether the benefits of these agents justify the additional costs for elderly Medicare recipients is particularly policy relevant after US health care reform...
  11. doi request reprint Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer
    C Daniel Mullins
    University of Maryland, School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA
    J Clin Oncol 30:661-6. 2012
    ....
  12. ncbi request reprint Indirect cost of HIV infection in England
    C D Mullins
    University of Maryland School of Pharmacy, Baltimore 21201, USA
    Clin Ther 22:1333-45. 2000
    ..Few studies have estimated the indirect costs of care for HIV infection in England by stage of infection at a population level...
  13. ncbi request reprint The direct medical costs of alpha(1)-antitrypsin deficiency
    C D Mullins
    University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Chest 119:745-52. 2001
    ..Such therapy consists of IV infusion of pooled human plasma alpha(1)-antiprotease...
  14. ncbi request reprint Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making
    C Daniel Mullins
    School of Pharmacy, Center on Drugs and Public Policy, University of Maryland, Baltimore, Maryland, USA
    Pharmacoeconomics 20:9-21. 2002
    ..Direct comparator studies are starting to emerge, but in limited numbers. The need for additional training of pharmaceutical representatives and PBM staff members remains a critical issue...
  15. ncbi request reprint Comparing cost-effectiveness analyses of anti-hypertensive drug therapy for decision making: mission impossible?
    C Daniel Mullins
    University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Value Health 5:359-71. 2002
    ..Cost calculations should be transparent and related to the perspective of the study. Modeling the cost-effectiveness of a drug may be an acceptable method provided that data sources and assumptions are valid and transparent...
  16. ncbi request reprint The economic impact of laparoscopic living-donor nephrectomy on kidney transplantation
    C Daniel Mullins
    Center on Drugs and Public Policy, The University of Maryland, Baltimore 21201, USA
    Transplantation 75:1505-12. 2003
    ..This study assessed the flow of expenditures from a Medicare perspective for laparoscopic donor nephrectomy compared with living and cadaveric transplantation and continued dialysis...
  17. ncbi request reprint Major components of the direct medical costs of alpha1-antitrypsin deficiency
    C Daniel Mullins
    University of Maryland School of Pharmacy, Center on Drugs and Public Policy, 2nd Floor, 515 W Lombard Street, Baltimore, MD 21201, USA
    Chest 124:826-31. 2003
    ..To examine the sources of the direct medical costs of alpha(1)-antitrypsin (AAT) deficiency based on survey data from affected individuals...
  18. ncbi request reprint Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy
    C Daniel Mullins
    University of Maryland School of Pharmacy, 515 W Lombard St, Room 262, Baltimore, MD 21201 1563, USA
    J Manag Care Pharm 9:150-8. 2003
    ..To estimate the annual cost and outcome impacts attributable to raloxifene, alendronate, and estrogen-progestin therapy as prevention therapies among postmenopausal women over the first 7 years of hormone replacement therapy (HRT)...
  19. ncbi request reprint Longitudinal versus cross-sectional methodology for estimating the economic burden of breast cancer: a pilot study
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Pharmacoeconomics 22:285-91. 2004
    ..This pilot study examined the differences in estimates that were obtained using these two methods, focusing on Maryland, US Medicaid reimbursement data for chemotherapy and prescription drugs for the years 1999-2000...
  20. pmc Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 W Lombard St, Second Floor, Baltimore, MD 21201, USA
    J Natl Med Assoc 96:809-16. 2004
    ..Given previous reports of variations in prevalence of cancer in low-income individuals, we sought to determine if disparities in cancer prevalence existed in a similarly-insured Medicaid population...
  21. ncbi request reprint Comparisons of hypertension-related costs from multinational clinical studies
    C Daniel Mullins
    University of Maryland Center on Drugs and Public Policy, Baltimore, Maryland, USA
    Pharmacoeconomics 22:1001-14. 2004
    ..This study identifies and compares the individual cost components of hospital and ambulatory services that manage the care of hypertensive patients in eight countries: the US, the UK, France, Spain, Germany, Italy, Canada and Australia...
  22. pmc Economic disparities in treatment costs among ambulatory Medicaid cancer patients
    C Daniel Mullins
    University of Maryland School of Pharmacy, Pharmaceutical Health Services Research Department, 515 W Lombard St, Second Floor, Baltimore MD 21201, USA
    J Natl Med Assoc 96:1565-74. 2004
    ..There are few studies examining disparities in treatment costs. Studies that do exist are dominated by the cost of hospital care...
  23. ncbi request reprint Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, 21201, USA
    Pharmacotherapy 25:660-7. 2005
    ..To compare persistence, switching, and discontinuation rates among patients taking brand-name selective serotonin reuptake inhibitors (SSRIs)...
  24. ncbi request reprint Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat
    C Daniel Mullins
    University of Maryland School of Pharmacy, 515 W Lombard St, 2nd Fl, Baltimore, MD 21201, USA
    J Manag Care Pharm 11:394-402. 2005
    ..DNT was further used to derive triptan treatment cost to achieve 100 successfully treated patients such that the cost-effectiveness of each treatment regime could be compared from the payer perspective...
  25. ncbi request reprint Variability and growth in spending for outpatient specialty pharmaceuticals
    C Daniel Mullins
    University of Maryland School of Pharmacy in Baltimore, USA
    Health Aff (Millwood) 24:1117-27. 2005
    ..Our results underscore the need for insurers to scrutinize trends in specialty pharmaceutical spending and identify appropriate management strategies...
  26. pmc Health disparities: a barrier to high-quality care
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore 21201, USA
    Am J Health Syst Pharm 62:1873-82. 2005
    ..Disparities in the treatment of cardiovascular disease, diabetes mellitus, and cancer among the sexes and racial groups and possible interventions are discussed...
  27. ncbi request reprint Effect of initial ziprasidone dose on treatment persistence in schizophrenia
    C Daniel Mullins
    University of Maryland School of Pharmacy, 515 W Lombard Street, Room 262, Baltimore, MD 21201, United States
    Schizophr Res 83:277-84. 2006
    ..To determine the relationship between ziprasidone initial dose and treatment persistence among patients diagnosed with schizophrenia...
  28. ncbi request reprint Comparison of first refill rates among users of sertraline, paroxetine, and citalopram
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Clin Ther 28:297-305; discussion 296. 2006
    ..Research suggests high rates of discontinuation of selective serotonin reuptake inhibitors (SSRIs)...
  29. ncbi request reprint Health plans' strategies for managing outpatient specialty pharmaceuticals
    C Daniel Mullins
    Pharmaceutical Health Services Research Department at the University of Maryland School of Pharmacy in Baltimore, USA
    Health Aff (Millwood) 25:1332-9. 2006
    ..3 percent of respondents. Other frequently implemented management strategies included claims review (82.8 percent), formulary management (76.7 percent), and utilization review (70 percent)...
  30. ncbi request reprint Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Clin Ther 28:1184-98. 2006
    ..This study compared the cost-effectiveness of linezolid and vancomycin in the treatment of patients with nosocomial pneumonia (NP) caused by methicillin-resistant Staphylococcus aureus (MRSA)...
  31. ncbi request reprint Formulary tier placement for commonly prescribed branded drugs: benchmarking and creation of a preferred placement index
    C Daniel Mullins
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Am J Manag Care 13:377-84. 2007
    ..To examine the relative preferred placement of commonly dispensed prescription drugs and to assess variations in drug coverage across a convenience sample of 12 health insurance plans...
  32. ncbi request reprint Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia
    C Daniel Mullins
    University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, United States
    Schizophr Res 98:8-15. 2008
    ..To compare discontinuation rates of atypical antipsychotic agents in patients with schizophrenia...
  33. doi request reprint Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study
    C Daniel Mullins
    University of Maryland, School of Pharmacy, Baltimore, Maryland 21201, USA
    Clin Ther 30:2204-16. 2008
    ..Intensive lipid-lowering therapy reduces cardiovascular (CV) event rates more than moderate therapy. Currently available generic statins cost less but provide less risk reduction...
  34. doi request reprint Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, Medicaid and other US government payers perspectives: the ISPOR Drug Cost Task Force report--Part IV
    C Daniel Mullins
    PHSR Department, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Value Health 13:18-24. 2010
    ..The objective of this study was to provide standards for estimating the cost of drugs financed by US public programs for utilization in pharmacoeconomic evaluations...
  35. pmc Health disparities in staging of SEER-medicare prostate cancer patients in the United States
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    Urology 76:566-72. 2010
    ..To examine whether race or age disparities affected the odds of being staged among prostate cancer (PC) patients. Accurate staging is critical for determining treatment for PC...
  36. doi request reprint Impact of patient sample on costs of events in pharmacoeconomic models
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD 21202, USA
    Expert Rev Pharmacoecon Outcomes Res 8:463-9. 2008
    ..Health services researchers should be deliberate in the choice of adverse event treatment costs that are used in decision analytic models. Future guidelines should seek to delineate best practices for cost calculations...
  37. doi request reprint The potential impact of comparative effectiveness research on the health of minority populations
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA
    Health Aff (Millwood) 29:2098-104. 2010
    ..We also recommend the increased recruitment of minorities for clinical trials, and such measures as using community health workers to translate research results in ways that will increase their relevance to minority patients...
  38. ncbi request reprint It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction
    C Daniel Mullins
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch St, 12th Floor, Baltimore, MD 21201, USA
    J Manag Care Pharm 17:S03-4. 2011
    ..The Patient Protection and Affordable Care Act brought considerable attention to comparative effectiveness research (CER).  ..
  39. ncbi request reprint Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix
    S E Brooks
    Department of Obstetrics and Gynecology and Reproductive Sciences, University of Maryland, Baltimore, Maryland 21201, USA
    Gynecol Oncol 79:107-15. 2000
    ....
  40. ncbi request reprint Exploring donors' and recipients' attitudes about living donor kidney transplantation
    Francoise G Pradel
    School of Pharmacy, Center on Drugs and Public Policy, University of Maryland, Baltimore, MD 21201, USA
    Prog Transplant 13:203-10. 2003
    ..There is a growing interest in living donor kidney transplantation because of its potential to reduce the current kidney shortage...
  41. ncbi request reprint Is there evidence of diminishing disparities in treatment (tx) with adjuvant (adj) chemotherapy (Ch) among elderly (E) stage 3 colon cancer (CC) patients (pts)? An analysis of 8,374 pts from SEER-Medicare data
    A J Davidoff
    University of Maryland School of Pharmacy, Baltimore, MD Johns Hopkins School of Medicine, Baltimore, MD sanofi aventis, Bridgewater, NJ
    J Clin Oncol 26:6574. 2008
    ..This population-based study identified sociodemographic factors that affect probability (Pr) of adj Ch, and determined whether disparities in tx decreased over time...
  42. doi request reprint Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data
    N N Hanna
    Department of Surgery, University of Maryland, Baltimore, Maryland 21201, USA
    Colorectal Dis 14:48-55. 2012
    ..It is unknown whether the cancer-specific survival benefit of chemotherapy differs across these nodal prognostic categories...
  43. ncbi request reprint Cost effectiveness of abciximab during routine medical practice
    S O Reed
    Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA
    Pharmacoeconomics 18:265-74. 2000
    ....
  44. ncbi request reprint Effect of age on survival benefit of adjuvant chemotherapy in elderly stage III colon cancer patients: a population-based analysis
    I H Zuckerman
    University of Maryland School of Pharmacy, Baltimore, MD University of Maryland School of Medicine, Baltimore, MD sanofi aventis, NJ Johns Hopkins University, Baltimore, MD
    J Clin Oncol 26:4014. 2008
    ..We estimated the modifying effect of age on the relationship between receipt of adjuvant chemotherapy (CH) and mortality among older patients with stage III CC...
  45. doi request reprint The economic burden of skeletal-related events among elderly men with metastatic prostate cancer
    J Jayasekera
    University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD, 21201, USA
    Pharmacoeconomics 32:173-91. 2014
    ..There is limited information available on Medicare costs associated with treating SREs. The objective of this study was to ascertain SRE-related costs among older men with metastatic prostate cancer in the US...
  46. ncbi request reprint Health disparities research--a model for conducting research on cancer disparities: characterization and reduction
    Claudia R Baquet
    University of Maryland School of Medicine, 685 West Baltimore Street, 618, Baltimore, MD 21201, USA
    J Assoc Acad Minor Phys 13:33-40. 2002
    ..The primary objective of the University of Maryland School of Medicine's grant is to reduce cancer rate disparities in underserved communities...
  47. ncbi request reprint Health care cost of analgesic use in hypertensive patients
    C Daniel Mullins
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
    Clin Ther 26:285-93. 2004
    ..Hypertension is one of the most frequently diagnosed chronic medical conditions in the United States and imposes a substantial financial and social burden on Americans...
  48. ncbi request reprint Factors associated with hospitalization costs for patients with community-acquired pneumonia
    Sanjay Merchant
    University of Maryland, School of Pharmacy, Baltimore, Maryland, USA
    Clin Ther 25:593-610. 2003
    ..The total cost of pneumonia, including indirect costs, was estimated to be approximately $23 billion per year in 1994...
  49. ncbi request reprint Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective
    Joshua S Benner
    ValueMedics Research, LLC, Arlington, VA, and University of Maryland, Baltimore, MD, USA
    Value Health 8:618-28. 2005
    ..The objective of this study was to identify the most cost-effective statin or combination of statins, from the perspective of a managed care payer...
  50. ncbi request reprint Disparities and trends in prostate cancer staging over time
    C D Mullins
    University of Maryland, Baltimore, MD
    J Clin Oncol 26:5160. 2008
    ..Differences in tumor extent and the likelihood of being appropriately staged exist across racial/ethnic and age groups. This study examined patterns of prostate cancer staging from a nationally representative dataset...
  51. ncbi request reprint Chemotherapy (C) and survival among 21,441 elderly (E) patients (pts) with advanced (adv) NSCLC: Analysis of SEER-Medicare claim data 1997-2002
    M Tang
    University of Maryland, Baltimore, MD University of Maryland School of Pharmacy, Baltimore, MD sanofi aventis, Bridgewater, NJ
    J Clin Oncol 26:8090. 2008
    ..8090 Background: C improves quality of life and survival in adv (Stage 3B w/ effusion and stage 4) NSCLC in clinical trials. Little is known about actual patterns of C and survival effects among E...
  52. ncbi request reprint Health care cost and utilization project analysis of comorbid illness and complications for patients undergoing hysterectomy for endometrial carcinoma
    S E Brooks
    Department of Obstetrics and Gynecology, School of Medicine, University of Maryland, 405 W Redwood Street 3rd Floor, Baltimore, MD 21201, USA
    Cancer 92:950-8. 2001
    ..The objective was to study the association of race, comorbid illness, and lymph node dissection (LND) with complications in patients undergoing hysterectomy for endometrial carcinoma...
  53. ncbi request reprint Dental visits to hospital emergency departments by adults receiving Medicaid: assessing their use
    Leonard A Cohen
    Department of Oral Health Care Delivery, University of Maryland Dental School, Baltimore 21201, USA
    J Am Dent Assoc 133:715-24; quiz 768. 2002
    ..People lacking access to private dental services may use hospital emergency departments, or EDs. In 1993, Maryland eliminated Medicaid reimbursement to dentists for adult emergency services...
  54. ncbi request reprint Patients' attitudes about living donor transplantation and living donor nephrectomy
    Francoise G Pradel
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Am J Kidney Dis 41:849-58. 2003
    ....
  55. ncbi request reprint The development of direct-to-consumer prescription drug advertising regulation
    Francis B Palumbo
    University of Maryland School of Pharmacy Center on Drugs and Public Policy, Baltimore, MD, USA
    Food Drug Law J 57:423-43. 2002
  56. pmc A Medicaid population's use of physicians' offices for dental problems
    Leonard A Cohen
    Department of Oral Health Care Delivery, University of Maryland Dental School, Baltimore 21201, USA
    Am J Public Health 93:1297-301. 2003
    ..This study evaluated how the elimination of Medicaid reimbursement to dentists for the treatment of adult dental problems affected patients' visits to physicians...
  57. ncbi request reprint Hospital admissions associated with nontraumatic dental emergencies in a Medicaid population
    Leonard A Cohen
    Department of Oral Health Care Delivery, University of Maryland Dental School, 666 West Baltimore Street, Baltimore, MD 21201, USA
    Am J Emerg Med 21:540-4. 2003
    ..Although some hospital admissions related to dental problems could be unavoidable, further studies are needed to better understand mechanisms for reducing the use of EDs for care best provided in community-based dental offices...
  58. ncbi request reprint Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost
    Ilene H Zuckerman
    Center on Drugs and Public Policy, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Am J Manag Care 10:493-500. 2004
    ....
  59. ncbi request reprint Prescription drug spending trends for the privately insured in Maryland, 2000-2001
    Fadia T Shaya
    Center on Drugs and Public Policy at the University of Maryland School of Pharmacy, USA
    Health Aff (Millwood) 23:226-32. 2004
    ..Findings suggest that a greater proportion of the economic burden of prescription drugs in coming years will be borne by those who use them...
  60. ncbi request reprint White paper: value of specialty certification in pharmacy
    Francoise G Pradel
    Center on Drugs and Public Policy, School of Pharmacy, University of Maryland, Baltimore 21201, USA
    J Am Pharm Assoc (2003) 44:612-20. 2004
    ....
  61. ncbi request reprint Medicaid coverage and utilization of adult dental services
    C Daniel Mullins
    School of Pharmarcy, University of Maryland, Baltimore, MD, USA
    J Health Care Poor Underserved 15:672-87. 2004
    ....
  62. ncbi request reprint Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population
    Fadia T Shaya
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA
    Arch Intern Med 165:181-6. 2005
    ..This observational cohort study examines the cardiovascular risk of COX-2 inhibitors compared with nonspecific NSAIDs in Maryland Medicaid enrollees, a high-risk population...
  63. ncbi request reprint Drug therapy persistence and stroke recurrence
    Fadia T Shaya
    Department of Epidemiology and Preventive Medicine, University of Maryland, 515 West Lombard St, Baltimore, MD 21201, USA
    Am J Manag Care 12:313-9. 2006
    ..To assess the effect of persistence of use of warfarin sodium, aspirin, or clopidogrel bisulfate on stroke recurrence in a Medicaid high-risk, largely female, African American population...
  64. ncbi request reprint Medication access through patient assistance programs
    Danielle Chauncey
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore 21201, USA
    Am J Health Syst Pharm 63:1254-9. 2006
  65. ncbi request reprint Cost-of-illness studies : a review of current methods
    Ebere Akobundu
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Pharmacoeconomics 24:869-90. 2006
    ..Comparisons and assessments of COI estimates should consider the method used to estimate costs both as an important source of variation in the reported COI estimates and as a marker of the reliability of the COI estimate...
  66. ncbi request reprint Center effects in anemia management of dialysis patients
    Jeffrey C Fink
    University of Maryland Medical System, Baltimore, MD 21201, USA
    J Am Soc Nephrol 18:646-53. 2007
    ..The presence of a center effect suggests that there are facility-specific processes that influence performance in dialysis anemia management and are independent of commonly titrated inputs, such as dosing of erythropoietic agents...
  67. ncbi request reprint Racial differences in hospital discharge disposition among stroke patients in Maryland
    Ebere Onukwugha
    University of Maryland, School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, MD 21201, USA
    Med Decis Making 27:233-42. 2007
    ..The objective of this retrospective study was to assess the evidence for racial differences in discharge disposition among patients hospitalized for stroke...
  68. doi request reprint Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system
    Ebere Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
    Value Health 11:980-8. 2008
    ..To identify a cost-saving subset of criteria for the use of tiotropium at a Veterans Affairs Medical Center based on a cost-effectiveness analysis with ipratropium as the comparator...
  69. doi request reprint Policy implications of drug importation
    Francis B Palumbo
    University of Maryland, School of Pharmacy, Center on Drugs and Public Policy, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
    Clin Ther 29:2758-67. 2007
    ....
  70. pmc Principles of economics crucial to pharmacy students' understanding of the prescription drug market
    Gail B Rattinger
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Room 01 220, Baltimore, Maryland 21201, USA
    Am J Pharm Educ 72:61. 2008
    ....
  71. pmc A survey of nephrologists' views on preemptive transplantation
    Francoise G Pradel
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, USA
    Clin J Am Soc Nephrol 3:1837-45. 2008
    ..Despite emerging evidence that preemptive transplantation is the best treatment modality for patients reaching end-stage renal disease (ESRD), it is underutilized. Nephrologists' views on preemptive transplantation are explored herein...
  72. doi request reprint Haemodialysis patients' readiness to pursue live donor kidney transplantation
    Francoise G Pradel
    Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, 220 Arch Street, Office level one, Baltimore, MD 21201, USA
    Nephrol Dial Transplant 24:1298-305. 2009
    ..Despite the benefits of live donor kidney transplantation (LDKT) over deceased donor kidney transplantation, patients hesitate to pursue this option...
  73. ncbi request reprint Short-term impact of an educational program promoting live donor kidney transplantation in dialysis centers
    Francoise G Pradel
    Department of Pharmaceutical Health Services Research, University of Maryland Baltimore School of Pharmacy, 220 Arch Street, Office level one, Baltimore, MD 21201, USA
    Prog Transplant 18:263-72. 2008
    ..Given the shortage of kidneys available for transplantation, a community-based intervention trial was implemented to assess the impact of an educational program on patients' access to live donor kidney transplantation (LDKT)...
  74. ncbi request reprint The total economic burden of overactive bladder in the United States: a disease-specific approach
    Ebere Onukwugha
    Department of Pharmaceutical Health Services Research, University of Maryland, School of Pharmacy, 220 Arch St, Baltimore, MD 21201, USA
    Am J Manag Care 15:S90-7. 2009
    ..To employ results from a recent US population-based survey to calculate disease-specific total costs of overactive bladder (OAB)...
  75. doi request reprint Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer
    Ilene H Zuckerman
    Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland 21201, USA
    J Am Geriatr Soc 57:1403-10. 2009
    ..To estimate the modifying effect of age on the survival benefit associated with adjuvant chemotherapy receipt in elderly patients with a diagnosis of Stage III colon cancer...
  76. doi request reprint Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation
    Amy J Davidoff
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 47:1229-36. 2009
    ..Recent healthcare system and environmental changes may have reduced treatment gaps...
  77. doi request reprint Cost-effectiveness of a motivational intervention to reduce rapid repeated childbearing in high-risk adolescent mothers: a rebirth of economic and policy considerations
    Beth Barnet
    Department of Family and Community Medicine, University of Maryland School of Medicine, 29 S Paca St Lower Level, Baltimore, MD 21201, USA
    Arch Pediatr Adolesc Med 164:370-6. 2010
    ..To determine the cost-effectiveness of an intervention that successfully reduced rapid repeated births within 2 years of an index birth to adolescent mothers...
  78. doi request reprint Health-related quality of life as a potential predictor in chronic obstructive lung disease patients
    Fadia T Shaya
    Associate Professor and Associate Director, University of Maryland, Center on Drugs and Public Policy, School of Pharmacy, 220 Arch Street, Room 01 204, Baltimore, MD 21201, USA
    Expert Rev Pharmacoecon Outcomes Res 7:129-35. 2007
    ..Over a 3-month period, no change was seen in the patient-reported health-related quality of life and the change in health-related quality-of-life scores was not associated with disease severity...
  79. pmc Reasons for discharges against medical advice: a qualitative study
    Eberechukwu Onukwugha
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
    Qual Saf Health Care 19:420-4. 2010
    ..The objective of this study is to identify the reasons for DAMA based on patient and multicategory provider focus-group interviews (FGIs)...
  80. doi request reprint The Breathmobile program: a good investment for underserved children with asthma
    Mary Elizabeth Bollinger
    Division of Pediatric Pulmonology Allergy, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Ann Allergy Asthma Immunol 105:274-281. 2010
    ..The Breathmobile, a specialty-based mobile asthma clinic, provides free care to underserved children. The cost of symptom-free day (SFD) improvement in this population has not been previously reported...
  81. ncbi request reprint Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics
    Nneka C Onwudiwe
    University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Baltimore, Maryland 21201, USA
    Ethn Dis 21:27-32. 2011
    ..Our goal was to explore patients' perceptions about barriers to self-management of diabetes that could possibly help explain poor health outcomes among minority patients...
  82. doi request reprint Readmissions after unauthorized discharges in the cardiovascular setting
    Eberechukwu Onukwugha
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Med Care 49:215-24. 2011
    ....
  83. ncbi request reprint Therapy (Tx) of locally advanced (LA) NSCLC in the elderly: Analysis of 6,325 patients from Surveillance, Epidemiology and End Results (SEER)-Medicare
    M J Edelman
    Greenebaum Cancer Center, Baltimore, MD University of Maryland School of Pharmacy, Baltimore, MD sanofi aventis, Bridgewater, NJ
    J Clin Oncol 26:7549. 2008
    ..Combined modality tx (CMT) (chemotherapy, C and radiation, R) is indicated for "fit" patients (pts) and is potentially curative. We examined population based tx patterns...
  84. ncbi request reprint The impact of docetaxel (D) in an older population of patients with advanced prostate cancer (PC): A simulation study using TAX327 and SEER Medicare data
    E Onukwugha
    University of Maryland School of Pharmacy, Baltimore, MD sanofi aventis, LLC, Bridgewater, NJ University of Maryland School of Medicine, Baltimore, MD
    J Clin Oncol 27:e16074. 2009
    ..This study sought to simulate the survival impact of D in a population of older pts with M1 PC on androgen deprivation therapy (ADT)...
  85. ncbi request reprint The impact of time of medical oncologist visit on survival among elderly patients with stage IV prostate cancer: An analysis using SEER-Medicare data
    C D Mullins
    University of Maryland, Baltimore, MD sanofi aventis, Bridgewater, NJ
    J Clin Oncol 27:e17509. 2009
    ..The objective of this study is to determine whether the time to a MOH visit is associated with survival...
  86. ncbi request reprint Characteristics of elderly metastatic prostate cancer (M1 PC) long-term survivors in the SEER Medicare database receiving androgen-deprivation therapy (ADT)
    N A Obeidat
    University of Maryland, Baltimore, MD sanofi aventis, Whitehouse Station, NJ
    J Clin Oncol 27:e17513. 2009
    ..This population-based analysis evaluated if long-term survivors (LT) receiving ADT possessed different characteristics relative to short-term survivors (ST)...
  87. ncbi request reprint Visit and treatment patterns over time among elderly patients (pts) with M1 prostate cancer (PC): An analysis using SEER-Medicare
    A Hussain
    University of Maryland Cancer Center, Baltimore, MD University of Maryland School of Pharmacy, Baltimore, MD sanofi aventis, Bridgewater, NJ
    J Clin Oncol 27:5170. 2009
    ..It is unknown whether visits to medical oncologists/hematologist oncologists (MOH) and treatment patterns are also changing over time. The objective of this study is to examine changes in visit and treatment patterns over time...
  88. ncbi request reprint Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis
    E M Perfetto
    Healthcentric Associates, Stevensville, Maryland, USA
    Clin Ther 23:1747-72. 2001
    ....
  89. ncbi request reprint Does earlier headache response equate to earlier return to functioning in patients suffering from migraine?
    F G Pradel
    Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
    Cephalalgia 26:428-35. 2006
    ..Rapid headache response is associated with faster return to functioning; rapid headache and functional responses are significant attributes of treatment acceptability...
  90. doi request reprint Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US
    John F P Bridges
    Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
    Pharmacoeconomics 28:175-84. 2010
    ..We conclude that while a threshold may be needed to interpret the results of a cost-effectiveness analysis, that threshold must vary across payers, populations and even procedures...
  91. doi request reprint Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer
    Nour A Obeidat
    Pharmaceutical Health Services Research Department, University of Maryland, Baltimore, Maryland, USA
    Am J Geriatr Pharmacother 7:343-54. 2009
    ..Few population-based studies have evaluated other chemotherapies that are now available for colorectal cancer management...
  92. ncbi request reprint Radiation oncologist visits and the effect on prostate cancer (PCa) survival among SEER-Medicare patients with stage IV disease
    E Onukwugha
    School of Pharmacy, University of Maryland, Baltimore, MD University of Maryland Cancer Center, Baltimore, MD
    J Clin Oncol 29:e15117. 2011
    ..We tested whether pre-treatment multi-specialist care (PTMSC) is associated with PCa-specific survival...
  93. ncbi request reprint Development of effectiveness guidance documents (EGDs) as a stakeholder-driven process for informing study designs for comparative effectiveness research (CER)
    M R Tiglao
    Center for Medical Technology Policy, Baltimore, MD School of Pharmacy, University of Maryland, Baltimore, MD Duke Cancer Institute, Durham, NC
    J Clin Oncol 29:e16617. 2011
    ..The Center for Medical Technology Policy (CMTP) developed a stakeholder-driven process to create EGDs to provide specific recommendations to product developers, sponsors and clinical researchers on designing CER studies...
  94. doi request reprint The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study
    F Y Hsiao
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, 220 Arch Street, 12th Floor, Baltimore, MD 21201, USA
    Diabetologia 53:489-96. 2010
    ....
  95. ncbi request reprint Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in the United States
    J C Choi
    Rutgers University, Piscataway, NJ Beth Israel Deaconess Medical Center, Boston, MA sanofi aventis, Bridgewater, NJ Smith Hanley Consulting Group, Lake Mary, FL University of Maryland School of Pharmacy, Baltimore, MD
    J Clin Oncol 27:1037. 2009
    ..The purpose of this study was to compare the risk of cardiotoxicity among three cohort groups: anthracycline-containing-chemotherapy (ACC), no-anthracycline-containing-chemotherapy (NACC), and no-chemotherapy (control) groups...
  96. ncbi request reprint Recommendations for designing comparative effectiveness studies in oncology
    R Montgomery
    Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD School of Pharmacy, University of Maryland, Baltimore, MD Duke Cancer Institute, Durham, NC University of Maryland Cancer Center, Baltimore, MD Center for Medical Technology Policy, Baltimore, MD
    J Clin Oncol 29:e16550. 2011
    ..Comparative effectiveness research (CER) can provide evidence to support this decision-making. However, oncology CER often lacks standards, making results difficult to cross-compare and interpret...
  97. ncbi request reprint Clinic visits and prescribing patterns among Veterans Affairs Maryland Health Care System dementia patients
    G B Rattinger
    Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy, Baltimore, MD, USA
    J Nutr Health Aging 14:677-83. 2010
    ....
  98. ncbi request reprint Discontinuation rates of topical glaucoma medications in a managed care population
    Fadia T Shaya
    Am J Manag Care 8:S271-7. 2002
    ..Rates of medication discontinuation reflect factors including effectiveness, tolerability, cost, and dosing frequency. Discontinuation data can be useful to physicians and health plan managers as they compare various glaucoma medications...
  99. ncbi request reprint Drug discounts for the uninsured
    C Daniel Mullins
    Clin Ther 25:1784-5. 2003
  100. ncbi request reprint Intervention for decreasing excessive acetaminophen use in Pennsylvania Medicaid recipients
    Ilene H Zuckerman
    Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore 21201, USA
    Am J Health Syst Pharm 61:2410-4. 2004
  101. ncbi request reprint Physician prescribing and the hippocratic oath
    C Daniel Mullins
    Clin Ther 27:628-9. 2005